News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Critical Therapeutics, Inc. (CRTX) Receives Notice of Additional Deficiency from NASDAQ


5/21/2008 8:45:08 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Critical Therapeutics, Inc. (NASDAQ: CRTX) announced today that on May 16, 2008 it received a letter from the NASDAQ Stock Market’s Listing Qualifications Department notifying the Company that its stockholders’ equity of $7,126,000, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 that it filed with the U.S. Securities and Exchange Commission (SEC) on May 12, 2008, does not comply with the minimum stockholders’ equity requirement of $10,000,000 for continued listing on The NASDAQ Global Market pursuant to NASDAQ Marketplace Rule 4450(a)(3). Given the Company’s failure to satisfy the minimum stockholders’ equity standard, the Listing Qualifications Staff is reviewing the Company’s eligibility for continued listing on The NASDAQ Global Market.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES